Polydex Pharmaceuticals (OTCMKTS:POLXF) Share Price Passes Below Two Hundred Day Moving Average – Here’s Why

Shares of Polydex Pharmaceuticals Ltd. (OTCMKTS:POLXF – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.99 and traded as low as $1.9860. Polydex Pharmaceuticals shares last traded at $1.9860, with a volume of 2,000 shares traded.

Polydex Pharmaceuticals Trading Up 0.3%

The business has a fifty day moving average price of $1.99 and a 200 day moving average price of $1.99.

About Polydex Pharmaceuticals

(Get Free Report)

Polydex Pharmaceuticals Ltd. is a development stage company, which engages in manufacturing of bulk pharmaceutical intermediates for the worldwide veterinary pharmaceutical industry, and the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.

See Also

• Five stocks we like better than Polydex Pharmaceuticals
• These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
• 3 Stocks Under $20 to Buy Before a Broader Market Rally
• Petco Faces Tough Competition, But Momentum Is Building
• The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It